Sysmex Signs Agreement with Mongolia’s Ministry of Health to Provide External Quality Assessment Support in the Field of Blood Morphology Testing
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has signed an agreement with Mongolia’s Ministry of Health to provide technological and scientific support and external quality assessment* support with the aim of raising the accuracy of blood morphology testing in Mongolia. A signing ceremony was held on September 15, 2017, in Ulaanbaatar, Mongolia.
In line with Mongolia’s economic growth in recent years, the country has been putting healthcare infrastructure in place. Mongolia’s Ministry of Health is playing a central role in initiatives to enhance the level of healthcare.
To date, Sysmex has supported external quality assessment in the country in the fields of hematology, clinical chemistry and immunochemistry based on agreements with Mongolia’s Ministry of Health. In this way, we have helped to increase the quality of clinical testing in the country.
In recent years, however, demand in Mongolia has grown for blood morphology testing, which is essential for the diagnosis, treatment and follow-up assessment of leukemia and other hematologic diseases. While clinical laboratory technologists can visually perform blood morphology testing to determine clinically useful information on the abnormal morphology of blood cells and platelets, such testing requires specialized knowledge and experience. Mongolia faces the issues of accumulating expertise and standardizing this testing.
To this end, when renewing its agreements with Mongolia’s Ministry of Health to provide external quality assessment support in the fields of hematology, clinical chemistry and immunochemistry, the scope was expanded to include the field of blood morphology testing.
With this support, Sysmex will provide local clinical laboratory technologists involved in blood morphology testing with the technological and scientific expertise the Company has accumulated through its global service and support activities. As in the fields of hematology, clinical chemistry and immunochemistry, Sysmex will support Mongolia’s Ministry of Health, which plays a central role, in creating and operating a nationwide framework for external quality assessment in blood morphology testing.
Through these activities, Sysmex will provide accurate technologies and knowledge related to blood morphology testing, helping to raise the quality of healthcare in Mongolia.
Going forward, Sysmex will continue striving to provide support for clinical testing in developing countries and emerging markets, contributing to the standardization and increased quality of clinical testing and thereby instilling trust and confidence in customers throughout the world.
Overview of the Agreement
| Agreement date: | July 1, 2017 |
| Content: | Technological and scientific support in the field of blood morphology testing, and activities to support the construction of an external quality assessment framework |
| Duration: | July 1, 2017 through June 30, 2020 |
Signing ceremony with Mongolia’s Ministry of Health
Terminology
| * | External quality assessment:
A method under which the same specimens (such as artificially produced blood) are distributed to multiple clinical laboratories, and the measurement results obtained are analyzed using statistical methods, thereby allowing the accuracy of individual laboratories’ measurement results to be evaluated. The results are provided as feedback to these laboratories, helping to increase the quality of testing. |
*Information contained in the press release is current as of the date of the announcement,
but may be subject to change without prior notice.
Comments are closed.